Skip to main content
SpringerLink
Log in

Evaluating Cognition in Patients with Chronic Obstructive Pulmonary Disease

  • Chapter
  • First Online:
Handbook on the Neuropsychology of Aging and Dementia

Part of the book series: Clinical Handbooks in Neuropsychology ((CHNEURO))

  • 4658 Accesses

Abstract

In this chapter, we focus on the neuropsychological evaluation of patients with chronic obstructive pulmonary disease (COPD), a common adult pulmonary disorder characterized by airflow limitation and shortness of breath. First, we will review the epidemiology and diagnostic criteria for COPD and discuss common medical comorbidities associated with COPD. Next, we will review the neuropsychological and neuroimaging literature focused on patients with COPD. Multidisciplinary rehabilitation is commonly prescribed for COPD patients. We will discuss the role of the neuropsychologist within the team. Finally, to more clearly illustrate the neuropsychological evaluation of patients with COPD, we will present a fictional case from our center with details regarding frequent referral questions, special considerations for the clinical interview, selection of cognitive tests, interpretation of tests, and final recommendations for the patient and/or the interdisciplinary rehabilitation team.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kochanek KD, Xu J, Murphy SL, Minino AM, Kung HC. Deaths: preliminary data for 2009. Natl Vital Stat Rep. 2011;59(4):1–51. Epub 2011/03/01. PubMed PMID: 25073815

    Google Scholar 

  2. Global Initiative for Chronic Obstructive Lung Disease I. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report): Global Initiative for Chornic Obstructive Lung Disease, Inc.; 2017. Available from: http://www.goldcopd.org/.

  3. Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet. 2006;367(9518):1216–9.

    Article  Google Scholar 

  4. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–63.

    Article  Google Scholar 

  5. Wain LV, Shrine N, Artigas MS, Erzurumluoglu AM, Noyvert B, Bossini-Castillo L, Obeidat M, Henry AP, Portelli MA, Hall RJ, Billington CK, Rimington TL, Fenech AG, John C, Blake T, Jackson VE, Allen RJ, Prins BP, Understanding Society Scientific G, Campbell A, Porteous DJ, Jarvelin MR, Wielscher M, James AL, Hui J, Wareham NJ, Zhao JH, Wilson JF, Joshi PK, Stubbe B, Rawal R, Schulz H, Imboden M, Probst-Hensch NM, Karrasch S, Gieger C, Deary IJ, Harris SE, Marten J, Rudan I, Enroth S, Gyllensten U, Kerr SM, Polasek O, Kahonen M, Surakka I, Vitart V, Hayward C, Lehtimaki T, Raitakari OT, Evans DM, Henderson AJ, Pennell CE, Wang CA, Sly PD, Wan ES, Busch R, Hobbs BD, Litonjua AA, Sparrow DW, Gulsvik A, Bakke PS, Crapo JD, Beaty TH, Hansel NN, Mathias RA, Ruczinski I, Barnes KC, Bosse Y, Joubert P, van den Berge M, Brandsma CA, Pare PD, Sin DD, Nickle DC, Hao K, Gottesman O, Dewey FE, Bruse SE, Carey DJ, Kirchner HL, Geisinger-Regeneron Discov EHRC, Jonsson S, Thorleifsson G, Jonsdottir I, Gislason T, Stefansson K, Schurmann C, Nadkarni G, Bottinger EP, Loos RJ, Walters RG, Chen Z, Millwood IY, Vaucher J, Kurmi OP, Li L, Hansell AL, Brightling C, Zeggini E, Cho MH, Silverman EK, Sayers I, Trynka G, Morris AP, Strachan DP, Hall IP, Tobin MD. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nat Genet. 2017;49(3):416–25. https://doi.org/10.1038/ng.3787. PubMed PMID: 28166213; PubMed Central PMCID: PMCPMC5326681.

    Article  Google Scholar 

  6. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, Hokanson JE, Washko G, Regan EA, Crapo JD, Silverman EK. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene study. Am J Respir Crit Care Med. 2011;184(4):414–20.

    Article  Google Scholar 

  7. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman RA, Celedon JC, Reilly JJ. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(6):2152–8.

    Article  Google Scholar 

  8. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2(5147):257–66.

    Article  Google Scholar 

  9. Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy NK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.

    Article  Google Scholar 

  10. Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JH, Grenier PA, Kauczor HU, Bailey WC, DeMeo DL, Casaburi RH, Friedman P, Van Beek EJ, Hokanson JE, Bowler RP, Beaty TH, Washko GR, Han MK, Kim V, Kim SS, Yagihashi K, Washington L, McEvoy CE, Tanner C, Mannino DM, Make BJ, Silverman EK, Crapo JD. Genetic epidemiology of CI. Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539–49. https://doi.org/10.1001/jamainternmed.2015.2735. PubMed PMID: 26098755; PubMed Central PMCID: PMCPMC4564354

    Article  Google Scholar 

  11. Hatipoglu U, Stoller JK. Alpha1-antitrypsin deficiency. Clin Chest Med. 2016;37(3):487–504. https://doi.org/10.1016/j.ccm.2016.04.011. PubMed PMID: 27514595.

    Article  Google Scholar 

  12. Stoller JK. Alpha-1 antitrypsin deficiency: an underrecognized, treatable cause of COPD. Cleve Clin J Med. 2016;83(7):507–14. https://doi.org/10.3949/ccjm.83a.16031. PubMed PMID: 27399863.

    Article  Google Scholar 

  13. Edgar R, Patel M, Bayliss S, Crossley D, Sapey E, Turner A. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. Int J Chron Obstruct Pulmon Dis. 2017;12:1295–308.

    Article  Google Scholar 

  14. Agusti A, Thomas A. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc. 2006;3(6):478–81.

    Article  Google Scholar 

  15. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc. 2007;4(7):522–5.

    Article  Google Scholar 

  16. Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, Calverley PM, Chavannes N, Dillard T, Fahy B. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932–46.

    Article  Google Scholar 

  17. Gan WQ, Man S, Senthilselvan A, Sin D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–80.

    Article  Google Scholar 

  18. Boussuges A, Rossi P, Gouitaa M, Nussbaum E. Alterations in the peripheral circulation in COPD patients. Clin Physiol Funct Imaging. 2007;27(5):284–90.

    Article  Google Scholar 

  19. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation. 2007;116(25):2992–3005. Epub 2007/12/19. doi: 10.1161/CIRCULATIONAHA.106.685206. PubMed PMID: 18086941.

    Article  Google Scholar 

  20. Maclay JD, McAllister DA, MacNee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology. 2007;12(5):634–41.

    Article  Google Scholar 

  21. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEniery CM, Donaldson K. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63(4):306–11.

    Article  Google Scholar 

  22. Dodd J, Getov S, Jones P. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–22.

    Article  Google Scholar 

  23. Hynninen KMJ, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59(6):429–43.

    Article  Google Scholar 

  24. Agle DP, Baum GL. Psychological aspects of chronic obstructive pulmonary disease. Med Clin N Am. 1977;61(4):749–58.

    Article  Google Scholar 

  25. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2006;12(2):113–7. Epub 2006/02/04. doi: 10.1097/01.mcp.0000208450.50231.c6. PubMed PMID: 16456380.

    Article  Google Scholar 

  26. Wamboldt FS. Anxiety and depression in COPD: a call (and need) for further research. COPD: J Chron Obstruct Pulmon Dis. 2005;2(2):199–201.

    Article  Google Scholar 

  27. Weaver TE, Narsavage GL. Physiological and psychological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res. 1992;41(5):286–91.

    Article  Google Scholar 

  28. Gift AG, McCrone SH. Depression in patients with COPD. Heart Lung. 1993;22(4):289–97. Epub 1993/07/01. PubMed PMID: 8360062.

    Google Scholar 

  29. Van Ede L, Yzermans C, Brouwer H. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688–92.

    Article  Google Scholar 

  30. Aydin IO, Uluşahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry. 2001;23(2):77–83.

    Article  Google Scholar 

  31. Agle DP, Baum GL, Chester EH, Wendt M. Multidiscipline treatment of chronic pulmonary insufficiency: 1. Psychologic aspects of rehabilitation. Psychosom Med. 1973;35(1):41–9.

    Article  Google Scholar 

  32. Goodglass H, Kaplan E. The assessment of aphasia and related disorders. Philadelphia: Lea and Febiger; 1983.

    Google Scholar 

  33. Eiser N, Harte R, Karvounis S, Phillips C, Isaac MT. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD: J Chron Obstruct Pulmon Dis. 2005;2(2):233–41.

    Article  Google Scholar 

  34. Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, Stanley MA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.

    Google Scholar 

  35. Kozora E, Emery C, Kaplan R, Wamboldt F, Zhang L, Make B. Cognitive and psychological issues in emphysema. Proc Am Thorac Soc. 2008;5:556–60. Epub 2008/05/06. doi: 10.1513/pats.200708-123ET. PubMed PMID: 18453371; PubMed Central PMCID: PMCPMC2645335.

    Article  Google Scholar 

  36. Ozge C, Ozge A, Unal O. Cognitive and functional deterioration in patients with severe COPD. Behav Neurol. 2006;17(2):121–30. PubMed PMID: 16873924.

    Article  Google Scholar 

  37. White J, Hopkins RO, Glissmeyer EW, Kitterman N, Elliott CG. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 2006;7:55. PubMed PMID: 16579853.

    Article  Google Scholar 

  38. Yohannes AM, Chen W, Moga AM, Leroi I, Connolly MJ. Cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: a systematic review and meta-analysis of observational studies. J Am Med Dir Assoc. 2017;18(5):451.e1–451.e11. https://doi.org/10.1016/j.jamda.2017.01.014. PubMed PMID: 28292570.

    Article  Google Scholar 

  39. Fix AJ, Golden CJ, Daughton D, Kass I, Bell CW. Neuropsychological deficits among patients with chronic obstructive pulmonary disease. Int J Neurosci. 1982;16(2):99–105. Epub 1982/03/01. PubMed PMID: 7166467.

    Article  Google Scholar 

  40. Grant I, Heaton RK, McSweeney AJ, Adams KM, Timms RM. Brain dysfunction in COPD. Chest. 1980;77(2 Suppl):308–9. Epub 1980/02/01. PubMed PMID: 7357924.

    Article  Google Scholar 

  41. Krop HD, Block AJ, Cohen E. Neuropsychologic effects of continuous oxygen therapy in chronic obstructive pulmonary disease. Chest. 1973;64(3):317–22.

    Article  Google Scholar 

  42. Prigatano GP, Parsons O, Levin DC, Wright E, Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. J Consult Clin Psychol. 1983;51(1):108.

    Article  Google Scholar 

  43. Incalzi RA, Marra C, Giordano A, Calcagni ML, Cappa A, Basso S, Pagliari G, Fuso L. Cognitive impairment in chronic obstructive pulmonary disease. J Neurol. 2003;250(3):325–32.

    Article  Google Scholar 

  44. Stuss D, Peterkin I, Guzman D, Guzman C, Troyer A. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol. 1997;19(4):515–24.

    Article  Google Scholar 

  45. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470–6. PubMed PMID: 7103628.

    Article  Google Scholar 

  46. Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis. 1993;148(2):418–24. PubMed PMID: 8342906.

    Article  Google Scholar 

  47. Prigatano GP, Parsons O, Wright E, Levin DC, Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary diseae. J Consult Clin Psychol. 1983;51(1):108–16.

    Article  Google Scholar 

  48. Etnier J, Johnston R, Dagenbach D, Pollard RJ, Rejeski WJ, Berry M. The relationships among pulmonary function, aerobic fitness, and cognitive functioning in older COPD patients. Chest. 1999;116(4):953–60. Epub 1999/10/26. PubMed PMID: 10531159.

    Article  Google Scholar 

  49. Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, Desjardins C, Parenteau S, Beaucage F, Joncas S, Monchi O, Gagnon JF. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142(6):1516–23. Epub 2013/02/01. doi: 10.1378/chest.11-3035. PubMed PMID: 23364388.

    Article  Google Scholar 

  50. Thakur N, Blanc PD, Julian LJ, Yelin EH, Katz PP, Sidney S, Iribarren C, Eisner MD. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Int J Chron Obstruct Pulmon Dis. 2010;5:263–9. Epub 2010/09/22. PubMed PMID: 20856825; PubMed Central PMCID: PMC2939681.

    Google Scholar 

  51. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, van Zomeren EH, Kerstjens HA. Cognitive performance in patients with COPD. Respir Med. 2004;98(4):351–6. Epub 2004/04/10. PubMed PMID: 15072176.

    Article  Google Scholar 

  52. Singh B, Mielke MM, Parsaik AK, Cha RH, Roberts RO, Scanlon PD, Geda YE, Christianson TJ, Pankratz VS, Petersen RC. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71(5):581–8.

    Article  Google Scholar 

  53. Dal Negro RW, Bonadiman L, Tognella S, Bricolo FP, Turco P. Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J Chron Obstruct Pulmon Dis. 2014;9:675.

    Article  Google Scholar 

  54. Voelkel NF, Gomez-Arroyo J, Mizuno S. COPD/emphysema: the vascular story. Pulm Circ. 2011;1(3):320–6.

    Article  Google Scholar 

  55. Pepin J-L, Cockcroft JR, Midwinter D, Sharma S, Rubin DB, Andreas S. Long-acting bronchodilators and arterial stiffness in patients with COPD: a comparison of fluticasone furoate/vilanterol with tiotropium. Chest. 2014;146(6):1521–30.

    Article  Google Scholar 

  56. Sievi NA, Franzen D, Kohler M, Clarenbach CF. Physical inactivity and arterial stiffness in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1891–7. Epub 2015/09/24. doi: 10.2147/COPD.S90943. PubMed PMID: 26392763; PubMed Central PMCID: PMCPMC4573078.

    Google Scholar 

  57. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychol. 2003;22(6):598–604. Epub 2003/12/04. doi: 10.1037/0278-6133.22.6.598. PubMed PMID: 14640857.

    Article  Google Scholar 

  58. Kozora E, Emery CF, Ellison MC, Wamboldt FS, Diaz PT, Make B. Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest. 2005;128(4):2653–63. PubMed PMID: 16236939.

    Article  Google Scholar 

  59. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, Mahurin R, Richards T, Anzai Y, Yukawa M, Yeh S. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008;3(3):429–34. PubMed Central PMCID: PMC2629981.

    Article  Google Scholar 

  60. Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32. PubMed Central PMCID: PMC4369069.

    Article  Google Scholar 

  61. Lahousse L, Tiemeier H, Ikram MA, Brusselle GC. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015;109(11):1371–80. PubMed PMID: 26342840.

    Article  Google Scholar 

  62. Kozora E, Filley CM, Julian LJ, Cullum CM. Cognitive functioning in patients with chronic obstructive pulmonary disease and mild hypoxemia compared with patients with mild Alzheimer disease and normal controls. Cogn Behav Neurol. 1999;12(3):178–83.

    Google Scholar 

  63. Zhang H, Wang X, Lin J, Sun Y, Huang Y, Yang T, Zheng S, Fan M, Zhang J. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. AJNR Am J Neuroradiol. 2013;34(2):334–9. Epub 2012/08/04. doi: 10.3174/ajnr.A3235. PubMed PMID: 22859277.

    Article  Google Scholar 

  64. Incalzi RA, Chiappini F, Fuso L, Torrice MP, Gemma A, Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med. 1998;92(3):527–33. PubMed PMID: 9692117.

    Article  Google Scholar 

  65. Li J, Fei GH. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res. 2013;14:140. Epub 2013/12/24. doi: 10.1186/1465-9921-14-140. PubMed PMID: 24359080; PubMed Central PMCID: PMC3878035.

    Article  Google Scholar 

  66. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186(3):240–5. Epub 2012/06/02. doi: 10.1164/rccm.201202-0355OC. PubMed PMID: 22652026.

    Article  Google Scholar 

  67. van Dijk EJ, Vermeer SE, de Groot JC, van de Minkelis J, Prins ND, Oudkerk M, Hofman A, Koudstaal PJ, Breteler MM. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75(5):733–6. Epub 2004/04/20. PubMed PMID: 15090569; PubMed Central PMCID: PMC1763550.

    Article  Google Scholar 

  68. Ryu CW, Jahng GH, Choi CW, Rhee HY, Kim MJ, Kim EJ, Choi WS. Microstructural change of the brain in chronic obstructive pulmonary disease: a voxel-based investigation by MRI. COPD. 2013;10(3):357–66. PubMed PMID: 23713596.

    Article  Google Scholar 

  69. Esser RW, Stoeckel MC, Kirsten A, Watz H, Taube K, Lehmann K, Peterson S, Magnussen H, von Leupoldt A. Structural brain changes in pateints with chronic obstructive pulmonary disease. Chest. 2015. https://doi.org/10.1378/chest.15-0027. PubMed PMID: 26203911.

    Article  Google Scholar 

  70. Chen J, Lin IT, Zhang H, Lin J, Zheng S, Fan M, Zhang J. Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface based morphometry and neuropsychological study. Brain Imaging Behav. 2015;10(2):464–76. epub. PubMed PMID: 25986304.

    Article  Google Scholar 

  71. Spilling CA, Jones PW, Dodd JW, Barrick TR. White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not. BMC Pulm Med. 2017;17(1):92. https://doi.org/10.1186/s12890-017-0435-1. PubMed PMID: 28629404; PubMed Central PMCID: PMCPMC5474872.

    Article  Google Scholar 

  72. Cleutjens F, Ponds R, Spruit MA, Burgmans S, Jacobs HIL, Gronenschild E, Staals J, Franssen FME, Dijkstra JB, Vanfleteren L, Hofman PA, Wouters EFM, Janssen DJA. The relationship between cerebral small vessel disease, hippocampal volume and cognitive functioning in patients with COPD: an MRI study. Front Aging Neurosci. 2017;9:88. https://doi.org/10.3389/fnagi.2017.00088. PubMed PMID: 28424613; PubMed Central PMCID: PMCPMC5371656.

    Article  Google Scholar 

  73. Toshima MT, Kaplan RM, Ries AL. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. Health Psychol. 1990;9(3):237.

    Article  Google Scholar 

  74. Emery CF, Leatherman NE, Burker EJ, MacIntyre NR. Psychological outcomes of a pulmonary rehabilitation program. J Cardiopulm Rehabil Prev. 1992;12(1):65–6.

    Article  Google Scholar 

  75. Kozora E, Tran ZV, Make B. Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2002;22(6):426–30.

    Article  Google Scholar 

  76. Kozora E, Emery CF, Zhang L, Make B. Improved neurobehavioral functioning in emphysema patients following medical therapy. J Cardiopulm Rehabil Prev. 2010;30(4):251–9.

    Article  Google Scholar 

  77. Greene CC, Bradley KA, Bryson CL, Blough DK, Evans LE, Udris EM, Au DH. The association between alcohol consumption and risk of COPD exacerbation in a veteran population. Chest. 2008;134(4):761–7.

    Article  Google Scholar 

  78. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  Google Scholar 

  79. Wechsler D. Australian and New Zealand language adaptation. In: Wechsler adult intelligence scale–fourth edition (WAIS-IV). San Antonio, TX: NCS Pearson Inc.; 2008.

    Google Scholar 

  80. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychology test battery. Tuscon: Neuropsychological Press; 1988.

    Google Scholar 

  81. Brandt J. The Hopkins verbal learning test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5(2):125–42.

    Article  Google Scholar 

  82. Benedict RH. Brief visuospatial memory test--revised: professional manual. Odessa: PAR; 1997.

    Google Scholar 

  83. Fastenau PS, Denburg NL, Mauer BA. Parallel short forms for the Boston naming test: psychometric properties and norms for older adults. J Clin Exp Neuropsychol. 1998;20(6):828–34.

    Article  Google Scholar 

  84. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia. 1967;5(2):135–40.

    Article  Google Scholar 

  85. Kozora E, Cullum CM. Qualitative features of clock drawings in normal aging and Alzheimer’s disease. Assessment. 1994;1(2):179–87.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Iowa, Iowa City, IA, USA

    Karin F. Hoth

  2. Department of Medicine, National Jewish Health, Denver, CO, USA

    Karin F. Hoth & Elizabeth Kozora

  3. Departments of Psychiatry and Neurology, University of Colorado School of Medicine at the Anschutz Medical Campus, Aurora, CO, USA

    Elizabeth Kozora

Authors
  1. Karin F. Hoth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Kozora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin F. Hoth .

Editor information

Editors and Affiliations

  1. Department of Neurology, Weill Cornell Medicine, New York, NY, USA

    Lisa D. Ravdin

  2. Department of Neurology, University of Miami, Miami, FL, USA

    Heather L. Katzen

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hoth, K.F., Kozora, E. (2019). Evaluating Cognition in Patients with Chronic Obstructive Pulmonary Disease. In: Ravdin, L.D., Katzen, H.L. (eds) Handbook on the Neuropsychology of Aging and Dementia. Clinical Handbooks in Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-93497-6_39

Download citation

Publish with us

Policies and ethics

Search

Navigation